Kenya and Uganda are among the countries selected for the Phase 1 clinical trial of an HIV vaccine. According to the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT), the first dose will be given in Lusaka, Zambia while Kenya and Uganda will receive the vaccines in a few weeks. Dr. William Kilembe, project director of the Center for
[elementor-template id="94265"]
